Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors.

Agrawal R, Jain P, Dikshit SN, Bahare RS.

Comb Chem High Throughput Screen. 2013 May;16(4):249-73.

PMID:
23305140
2.
3.

3D QSAR of aminophenyl benzamide derivatives as histone deacetylase inhibitors.

Mahipal, Tanwar OP, Karthikeyan C, Moorthy NS, Trivedi P.

Med Chem. 2010 Sep;6(5):277-85.

PMID:
20977417
4.

Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents.

Agrawal R, Jain P, Dikshit SN.

Comb Chem High Throughput Screen. 2012 Dec;15(10):849-76.

PMID:
23140189
5.

Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.

Jiang YK.

J Mol Model. 2010 Jul;16(7):1239-49. doi: 10.1007/s00894-009-0637-4. Epub 2010 Jan 13.

PMID:
20069322
6.

Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors.

Teli MK, Rajanikant GK.

J Enzyme Inhib Med Chem. 2012 Aug;27(4):558-70. doi: 10.3109/14756366.2011.603128. Epub 2011 Aug 18.

PMID:
21851209
7.

Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.

Lin K, Cai Z, Wang F, Zhang W, Zhou W.

Chem Pharm Bull (Tokyo). 2013;61(4):477-82. Epub 2013 Jan 28.

8.

In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.

Nongonierma AB, Mooney C, Shields DC, FitzGerald RJ.

Peptides. 2014 Jul;57:43-51. doi: 10.1016/j.peptides.2014.04.018. Epub 2014 May 2.

PMID:
24793774
9.
10.

Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.

Wu D, Jin F, Lu W, Zhu J, Li C, Wang W, Tang Y, Jiang H, Huang J, Liu G, Li J.

Chem Biol Drug Des. 2012 Jun;79(6):897-906. doi: 10.1111/j.1747-0285.2012.01365.x. Epub 2012 Mar 21.

PMID:
22381062
11.

Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.

Al-Masri IM, Mohammad MK, Taha MO.

ChemMedChem. 2008 Nov;3(11):1763-79. doi: 10.1002/cmdc.200800213.

PMID:
18989859
12.

Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP- IV).

Paliwal S, Seth D, Yadav D, Yadav R, Paliwal S.

J Enzyme Inhib Med Chem. 2011 Feb;26(1):129-40. doi: 10.3109/14756361003777057.

PMID:
21299434
13.

Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.

Sharma M, Gupta M, Singh D, Kumar M, Kaur P.

Chem Biol Drug Des. 2012 Dec;80(6):918-28. doi: 10.1111/cbdd.12041. Epub 2012 Oct 12.

PMID:
22943413
14.

Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations.

Tanwar O, Deora GS, Tanwar L, Kumar G, Janardhan S, Alam M, Shaquiquzzaman, Akhter M.

J Mol Model. 2014 Apr;20(4):2118. doi: 10.1007/s00894-014-2118-7. Epub 2014 Apr 1.

PMID:
24687332
15.

CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements.

Murugesan V, Sethi N, Prabhakar YS, Katti SB.

Mol Divers. 2011 May;15(2):457-66. doi: 10.1007/s11030-010-9267-0. Epub 2010 Aug 25.

PMID:
20737212
16.

Scaffold-based design of xanthine as highly potent inhibitors of DPP-IV for improving glucose homeostasis in DIO mice.

Ran Y, Pei H, Xie C, Ma L, Wu Y, Lei K, Shao M, Tang M, Xiang M, Peng A, Wei Y, Chen L.

Mol Divers. 2015 May;19(2):333-46. doi: 10.1007/s11030-015-9570-x. Epub 2015 Feb 12.

PMID:
25672287
17.

Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.

Tyagi C, Grover S, Dhanjal J, Goyal S, Goyal M, Grover A.

BMC Genomics. 2013;14 Suppl 8:S10. doi: 10.1186/1471-2164-14-S8-S10. Epub 2013 Dec 9.

18.

A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors.

Lu IL, Tsai KC, Chiang YK, Jiaang WT, Wu SH, Mahindroo N, Chien CH, Lee SJ, Chen X, Chao YS, Wu SY.

Eur J Med Chem. 2008 Aug;43(8):1603-11. doi: 10.1016/j.ejmech.2007.11.014. Epub 2007 Nov 29. Erratum in: Eur J Med Chem. 2009 Jun;44(6):2763.

PMID:
18207285
19.

3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.

Pissurlenkar RR, Shaikh MS, Coutinho EC.

J Mol Model. 2007 Oct;13(10):1047-71. Epub 2007 Aug 4.

PMID:
17676345
20.

Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.

Dong J, Gong Y, Liu J, Chen X, Wen X, Sun H.

Bioorg Med Chem. 2014 Feb 15;22(4):1383-93. doi: 10.1016/j.bmc.2013.12.061. Epub 2014 Jan 7.

PMID:
24457090
Items per page

Supplemental Content

Write to the Help Desk